DiaSorin SpA - ESG Rating & Company Profile powered by AI
This ESG assessment for DiaSorin SpA indicates its reporting of the UN Sustainable Development Goals. This page is a zero-cost Environmental, Social and Governance report covering DiaSorin SpA. This ESG rating includes seventeen United Nations Sustainable Development Goals including: 'Quality Education', 'Climate Action' and 'Life on Land'.
DiaSorin SpA in the Medical Equipment, Supplies & Distribution industry gained a UN SDG ESG Transparency Score of 4.1; made up of an environmental score of 4.0, social score of 2.7 and governance score of 5.3.
4.1
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Becton Dickinson and Co | 8.6 | High |
| 2 | DENTSPLY SIRONA Inc | 8.4 | High |
| 247 | STAAR Surgical Co | 4.2 | High |
| 247 | Supermax Corporation Bhd | 4.2 | High |
| 252 | DiaSorin SpA | 4.1 | High |
| 252 | Daiken Medical Co Ltd | 4.1 | High |
| 252 | Thermogenesis Holdings Inc | 4.1 | High |
| ... | ... | ... | |
| 526 | Valeritas Holdings Inc | 0.0 | Low |
| 526 | ZoomMed Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does DiaSorin SpA have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes DiaSorin SpA disclose current and historical energy intensity?
Sign up for free to unlockDoes DiaSorin SpA report the average age of the workforce?
Sign up for free to unlockDoes DiaSorin SpA reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes DiaSorin SpA disclose its ethnicity pay gap?
Sign up for free to unlockDoes DiaSorin SpA disclose cybersecurity risks?
Sign up for free to unlockDoes DiaSorin SpA offer flexible work?
Sign up for free to unlockDoes DiaSorin SpA have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes DiaSorin SpA disclose the number of employees in R&D functions?
Sign up for free to unlockDoes DiaSorin SpA conduct supply chain audits?
Sign up for free to unlockDoes DiaSorin SpA disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes DiaSorin SpA conduct 360 degree staff reviews?
Sign up for free to unlockDoes DiaSorin SpA disclose the individual responsible for D&I?
Sign up for free to unlockDoes DiaSorin SpA disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes DiaSorin SpA disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes DiaSorin SpA disclose water use targets?
Sign up for free to unlockDoes DiaSorin SpA have careers partnerships with academic institutions?
Sign up for free to unlockDid DiaSorin SpA have a product recall in the last two years?
Sign up for free to unlockDoes DiaSorin SpA disclose incidents of discrimination?
Sign up for free to unlockDoes DiaSorin SpA allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas DiaSorin SpA issued a profit warning in the past 24 months?
Sign up for free to unlockDoes DiaSorin SpA disclose parental leave metrics?
Sign up for free to unlockDoes DiaSorin SpA disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes DiaSorin SpA disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes DiaSorin SpA disclose the pay ratio of women to men?
Sign up for free to unlockDoes DiaSorin SpA support suppliers with sustainability related research and development?
Sign up for free to unlockDoes DiaSorin SpA disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes DiaSorin SpA reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs DiaSorin SpA involved in embryonic stem cell research?
Sign up for free to unlockDoes DiaSorin SpA disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes DiaSorin SpA disclose its waste policy?
Sign up for free to unlockDoes DiaSorin SpA report according to TCFD requirements?
Sign up for free to unlockDoes DiaSorin SpA disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes DiaSorin SpA disclose energy use targets?
Sign up for free to unlockDoes DiaSorin SpA disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes DiaSorin SpA have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for DiaSorin SpA
These potential risks are based on the size, segment and geographies of the company.
DiaSorin S.p.A. develops, manufactures, and distributes immunodiagnostics and molecular diagnostics testing kits in Europe, Africa, North America, Central and South America, the Asia Pacific, and China. The company provides various immunodiagnostic LIAISON platforms, including LIAISON XS, LIAISON XL, and LIAISON XL LAS; and molecular diagnostics platform comprising of LIAISON MDX for use in the amplification of nucleic acids to diagnose viral infections through the identification of virus in patient's biological sample. It has partnership agreements with QIAGEN for diagnostic solution for Latent Tuberculosis detection; TTP for the development of molecular Point-of-Care solution; and MeMed for the launch of a test differentiating between viral and bacterial infections. The company was founded in 1968 and is headquartered in Saluggia, Italy.